These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22092781)

  • 1. Management of severe anogenital acne inversa (hidradenitis suppurativa).
    Wollina U; Tilp M; Meseg A; Schönlebe J; Heinig B; Nowak A
    Dermatol Surg; 2012 Jan; 38(1):110-7. PubMed ID: 22092781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report.
    Wollina U; Langner D; Heinig B; Nowak A
    Int J Dermatol; 2017 Jan; 56(1):109-115. PubMed ID: 27495143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?
    Boer J; Nazary M
    Br J Dermatol; 2011 Jan; 164(1):170-5. PubMed ID: 20874789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in anatomical area-specific wound healing in hidradenitis suppurativa/acne inversa after surgery.
    Frings VG; Bauer B; Schuster R; Goebeler M; Presser D; Kerstan A
    Eur J Dermatol; 2021 Oct; 31(5):623-629. PubMed ID: 34789440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases].
    Bordier-Lamy F; Palot JP; Vitry F; Bernard P; Grange F
    Ann Dermatol Venereol; 2008 May; 135(5):373-9. PubMed ID: 18457723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions.
    van der Zee HH; Prens EP; Boer J
    J Am Acad Dermatol; 2010 Sep; 63(3):475-80. PubMed ID: 20708472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.
    Boer J; Jemec GB
    Clin Exp Dermatol; 2010 Jan; 35(1):36-40. PubMed ID: 19549239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory drugs alone and adjuvant to surgery for hidradenitis suppurativa/acne inversa-A narrative review.
    Wollina U; Brzezinski P; Koch A; Philipp-Dormston WG
    Dermatol Ther; 2020 Nov; 33(6):e13877. PubMed ID: 32558202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychophysical aspects of hidradenitis suppurativa.
    Matusiak L; Bieniek A; Szepietowski JC
    Acta Derm Venereol; 2010 May; 90(3):264-8. PubMed ID: 20526543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of surgical management of stage III vulvar hidradenitis suppurativa.
    Rhode JM; Burke WM; Cederna PS; Haefner HK
    J Reprod Med; 2008 Jun; 53(6):420-8. PubMed ID: 18664060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of Verneuil's disease (hidradenitis suppurativa): 15 cases].
    Lamfichekh N; Dupond AS; Destrumelle N; Runser C; Humbert P; Mantion G
    Ann Dermatol Venereol; 2001 Feb; 128(2):127-9. PubMed ID: 11275587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.
    Sartorius K; Emtestam L; Jemec GB; Lapins J
    Br J Dermatol; 2009 Oct; 161(4):831-9. PubMed ID: 19438453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives in the treatment of hidradenitis suppurativa: surgery and brewer's yeast-exclusion diet.
    Cannistrà C; Finocchi V; Trivisonno A; Tambasco D
    Surgery; 2013 Nov; 154(5):1126-30. PubMed ID: 23891479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
    Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A
    Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.